172 Effect of Race on Treatment Choice and Outcomes for Peyronie's Disease

Abstract

Peyronie’s disease (PD) is a debilitating progressive fibrotic disorder of the penis that can lead to significant pain, erectile dysfunction, and emotional distress. Traditionally considered a disease of middle-aged Caucasian men, PD is now seen in a wider demographic of patients seeking evaluation and treatment. This trend may be attributable to increased awareness of the condition. Within this more diverse patient population, PD treatment and outcome satisfaction can be highly patient specific and may be dependent on multiple factors. We sought to evaluate the influence of patient race on treatment choice and outcomes among a contemporary cohort of men with PD. We conducted a retrospective chart review of all 18-70 year old men presenting to our academic medical center between 1/1/2012 to 12/31/2016 for evaluation and treatment of PD. Information on age, race, medical comorbidities, severity of penile deformity, treatment choice(s), and treatment outcomes was abstracted from the electronic medical record. Severity of penile deformity was based on objective curvature assessment at time of penile Doppler ultrasound (PDUS). Only patients who completed treatment(s) for PD at our institution were included in the final analysis of treatment outcomes and treatment satisfaction.